Cartography Biosciences Appoints Industry Veteran as Chief Administrative and Legal Officer

2023-05-25

高管变更免疫疗法

Blaine Templeman will support the team’s mission to develop more precise and effective cancer immunotherapies for patients SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Cartography Biosciences, an immuno-oncology company creating biologic therapies against novel targets guided by the first-ever comprehensive antigen atlas, today announced the appointment of Blaine Templeman as Chief Administrative and Legal Officer. “With nearly three decades of experience supporting immuno-oncology and vaccine companies, Blaine brings a lifetime of experience to the operations of Cartography,” said Kevin Parker, Ph.D., co-founder and CEO of Cartography Biosciences. “We’re excited to tap into Blaine’s broad experience in the industry and have him play an integral role in our strategy and growth as our team translates our novel immuno-oncology targets to therapeutic programs.” Mr. Templeman continues at Cartography after serving as the company’s interim Chief Operating Officer. In his new role, Mr. Templeman will oversee Cartography’s administrative operations, including managing the company’s worldwide legal affairs, compliance, facilities, finance, human resources, risk management, and other administrative functions. “I am inspired by Cartography’s mission and innovative team – working tirelessly to find the safest, most effective targets for oncology patients in need,” said Mr. Templeman. “I look forward to guiding and growing the company’s operations and supporting the development of a smarter and more efficient path for precision therapeutics.” Having represented many biotechnology companies in various roles, Mr. Templeman most recently provided strategic support to companies such as Sairopa BV and Shiru, Inc. prior to joining Cartography. Previously, Mr. Templeman was the Chief Administrative and Legal Officer at Aduro Biotech and a corporate and intellectual property transactions partner at Arnold & Porter LLP, the managing partner of the New York office of Sheppard Mullin LLP and partner at Heller Ehrman LLC. He holds a Juris Doctor from New York University School of Law, studied at Princeton Seminary, and received a B.A. from Oral Roberts University. About Cartography Biosciences Cartography Biosciences is focused on developing tumor-selective therapeutics that are based on a unique genomics and computational platform. Cartography’s platform integrates data from proprietary sample sourcing relationships, an industry-leading comprehensive reference atlas, and our target identification algorithms to identify the cells of interest and the single or pairs of targets that are most specific to the intended target cells. Cartography is unlocking the full potential of immunotherapy by discovering and developing therapeutics as precise as their targets. To learn more about Cartography and our mission to treat every patient with cancer, visit cartography.bio and follow us on LinkedIn and Twitter @cartographybio. View source version on businesswire.com: Contacts Media: MacDougall Advisors Karen Sharma ksharma@macdougall.bio 781-235-3060 Source: Cartography Biosciences View this news release online at:

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构